Study Stopped
This observational, retrospective study was discontinued as part of a strategic decision to reallocate resources to new product development. All patients had completed treatment before the study start.
Retrospective Study on Clinical Performance and Safety Profile of MJ-Flex Elastic Nail
MJ-Flex
Multicenter Retrospective Observational Study to Assess the Clinical Performance and Safety Profile of MJ-FLEX in Paediatric Patients Who Have Suffered Diaphyseal Fractures of Long Bones in Daily Practice: MJ-FLEX Study
2 other identifiers
observational
6
1 country
1
Brief Summary
This study aims to retrospectively collect data from routine clinical practice in order to evaluate the safety profile of the MJ-FLEX elastic nail used in pediatric patients according to the manufacturer Instructions For Use (IFU) in the time frame from the time of surgery until the last follow-up visit available at the hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2024
CompletedFirst Posted
Study publicly available on registry
May 14, 2024
CompletedStudy Start
First participant enrolled
July 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2025
CompletedAugust 28, 2025
August 1, 2025
8 months
April 30, 2024
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Percentage of procedures that have achieved bone union at the "bone consolidation assessment" visit
The measurement of efficacy will be mande with the percentage of procedures that have achieved bone union
After 5 month (approximately) from surgery
Percentage of procedures with at least one serious/not serious adverse event certainly related or possibly related to MJ-FLEX (ADEs/SADEs)
This outcome will be used to measure safety
from the date of surgery until the last follow-up, assessed up to 1 year
Percentage of procedures who experienced at least one MDDs that caused an effect on the patient
This outcome will be used to measure safety
from the date of surgery until the last follow-up, assessed up to 1 year
Post-treatment fracture-free survival
This outcome will be used to measure safety
up to 1 year
Study Arms (1)
Patients in pediatric age (> 18 month and < 18 years) at the time of surgery
The full analysis set includes all paediatric patients who that have been treated for diaphyseal fractures of long bones with the MJ-FLEX the will be systematically consecutive screened at the centers.
Interventions
Intramedullary implantation of the MJ-Flex elastic nail in long bones to provide bone fixation
Eligibility Criteria
The full analysis set includes all paediatric patients who that have been treated for diaphyseal fractures of long bones with the MJ-FLEX the will be systematically consecutive screened at the centers.
You may qualify if:
- The patient has been adequately informed by providing the PIS. 1.1 The patient expressed his willingness to participate in the Study by signing and dating informed consent (valid only for UK patients according to local law).
- Patients who had a regular indication for surgical intervention with MJ-Flex according to the manufacturer's IFU.
- Patients in pediatric age (\> 18 month and \< 18 years) at the time of surgery.
- Patients skeletally immature.
- Patients who underwent surgery performed with MJ-Flex.
- Patients with clinical data registered in her/him medical records sufficient to assess the safety and efficacy endpoint of the study: in particular, the patient has at least one follow-up at minimum 3 months from the surgery where is possible for the investigator to assess the consolidation of the treated bone.
- The patient had surgery at least 1 year before enrollment.
You may not qualify if:
- Patient who had/has a medical condition that is a contraindication according to the manufacturer's instruction for use leaflet.
- Patient who had/has a concomitant not permitted device which cannot be safely removed.
- Patient for whom there are other concurrent medical or other conditions that in the opinion of the participating investigator may prevent participation or otherwise render the patient ineligible for the study.
- The patient had surgery less than 1 year before enrollment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Orthofix s.r.l.lead
Study Sites (1)
Sheffield Children's NHS Foundation Trust
Sheffield, S10 2TH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Dorman, MD
Sheffield Children's NHS Foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2024
First Posted
May 14, 2024
Study Start
July 19, 2024
Primary Completion
March 28, 2025
Study Completion
March 28, 2025
Last Updated
August 28, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share